| Primary information |
|---|
| ID | antitb_1550, |
| Name | 25613372 |
| N-Terminal modification | Lacticin 3147 |
| C-Terminal Modification | AA-(Dhb)-N-(Dhb)-FALADYWGNNGAWA-(Abu)-L-(Abu)-HEAMAWAK |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Dhb= Didehydroaminobutyric acid, Abu= 2-aminobutyric acid |
| Chirality | Linear |
| Nature | 30 |
| Source | L |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from Lactococcus lactis |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Ra |
| Cell Line | IC90= 7.5 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1551, |
| Name | 25613372 |
| N-Terminal modification | Lacticin 3147 |
| C-Terminal Modification | AA-(Dhb)-N-(Dhb)-FALADYWGNNGAWA-(Abu)-L-(Abu)-HEAMAWAK |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Dhb= Didehydroaminobutyric acid, Abu= 2-aminobutyric acid |
| Chirality | Linear |
| Nature | 30 |
| Source | L |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from Lactococcus lactis |
| Inhibition Concentration | Mycobacterium avium |
| In Vitro/ In vivo | Mycobacterium avium |
| Cell Line | IC90= 60 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1552, |
| Name | 25613372 |
| N-Terminal modification | Lacticin 3147 |
| C-Terminal Modification | AA-(Dhb)-N-(Dhb)-FALADYWGNNGAWA-(Abu)-L-(Abu)-HEAMAWAK |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | Dhb= Didehydroaminobutyric acid, Abu= 2-aminobutyric acid |
| Chirality | Linear |
| Nature | 30 |
| Source | L |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from Lactococcus lactis |
| Inhibition Concentration | Mycobacterium Kansaii |
| In Vitro/ In vivo | Mycobacterium Kansaii |
| Cell Line | IC90= 15 μg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |